Literature DB >> 1383597

A cell-type specific ganglioside of glomerular podocytes in rat kidney: an O-acetylated GD3.

J Reivinen1, H Holthöfer, A Miettinen.   

Abstract

We recently described a monoclonal antibody (clone 27A) that detected a membrane antigen specific for glomerular podocytes in adult rat kidney. After binding in vivo, the antibodies induced rapid changes in the foot processes. Here we show that in other rat tissues the antigen is detectable only in cells of adrenal medulla, in some cells of neural or neural crest origin, and in 1 to 5% of the cells of a rat pheochromocytoma cell line PC-12. Attempts to isolate the antigen revealed that it is an acidic, sialic acid containing lipid, as shown by thin layer chromatography and immuno-overlay techniques. Further characterization of the gangliosides extracted from rat glomeruli, bovine kidney, rat adrenal glands, or from PC-12 cells by ion exchange, thin layer, and gas liquid chromatography identified the antigenic lipid as a modified disialosyllactosylceramide (GD3). The results of mild alkaline treatment or periodate oxidation of the antigenic ganglioside, as well as chemical O-acetylation studies of standard gangliosides, showed that the modified ganglioside is O-acetylated, most probably at the 9-carbon of its terminal sialic acid residue. To our knowledge this is the first report of cell-type specific expression of gangliosides in the kidney.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383597     DOI: 10.1038/ki.1992.327

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  19 in total

1.  Developmental expression of the nephritogenic antigen of monoclonal antibody 5-1-6.

Authors:  H Kawachi; D R Abrahamson; P L St John; D J Goldstein; M A Shia; K Matsui; F Shimizu; D J Salant
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

Review 2.  Lipid biology of the podocyte--new perspectives offer new opportunities.

Authors:  Alessia Fornoni; Sandra Merscher; Jeffrey B Kopp
Journal:  Nat Rev Nephrol       Date:  2014-05-27       Impact factor: 28.314

Review 3.  Structure and function of podocytes: an update.

Authors:  P Mundel; W Kriz
Journal:  Anat Embryol (Berl)       Date:  1995-11

4.  Decrease of glomerular disialogangliosides in puromycin nephrosis of the rat.

Authors:  H Holthöfer; J Reivinen; M L Solin; A Haltia; A Miettinen
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

5.  Involvement of lipid rafts in nephrin phosphorylation and organization of the glomerular slit diaphragm.

Authors:  M Simons; K Schwarz; W Kriz; A Miettinen; J Reiser; P Mundel; H Holthöfer
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

6.  Podocalyxin in rat platelets and megakaryocytes.

Authors:  A Miettinen; M L Solin; J Reivinen; E Juvonen; R Väisänen; H Holthöfer
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

7.  Cloning and expression of the rat nephrin homolog.

Authors:  H Ahola; S X Wang; P Luimula; M L Solin; L B Holzman; H Holthöfer
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

8.  9-O-acetylated sialic acids have widespread but selective expression: analysis using a chimeric dual-function probe derived from influenza C hemagglutinin-esterase.

Authors:  A Klein; M Krishna; N M Varki; A Varki
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

9.  Interferon-gamma (IFN-gamma) and IL-4 expressed during mercury-induced membranous nephropathy are toxic for cultured podocytes.

Authors:  W Coers; J T Vos; P H Van der Meide; M L Van der Horst; S Huitema; J J Weening
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

10.  Podocyte expression of MHC class I and II and intercellular adhesion molecule-1 (ICAM-1) in experimental pauci-immune crescentic glomerulonephritis.

Authors:  W Coers; E Brouwer; J T Vos; A Chand; S Huitema; P Heeringa; C G Kallenberg; J J Weening
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.